KE3581A - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
KE3581A
KE3581A KE358185A KE358185A KE3581A KE 3581 A KE3581 A KE 3581A KE 358185 A KE358185 A KE 358185A KE 358185 A KE358185 A KE 358185A KE 3581 A KE3581 A KE 3581A
Authority
KE
Kenya
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
KE358185A
Inventor
Harry William Burnstead
David John Rooke
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP81304086A external-priority patent/EP0049061B1/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of KE3581A publication Critical patent/KE3581A/en

Links

KE358185A 1980-09-27 1985-11-25 Pharmaceutical formulation KE3581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8031298 1980-09-27
EP81304086A EP0049061B1 (en) 1980-09-27 1981-09-08 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
KE3581A true KE3581A (en) 1986-01-17

Family

ID=26082421

Family Applications (1)

Application Number Title Priority Date Filing Date
KE358185A KE3581A (en) 1980-09-27 1985-11-25 Pharmaceutical formulation

Country Status (1)

Country Link
KE (1) KE3581A (en)

Similar Documents

Publication Publication Date Title
DE3172028D1 (en) Pharmaceutical formulation
ZA828797B (en) Pharmaceutical formulation
ZA813465B (en) Pharmaceutical composition
PH19245A (en) Pharmaceutical preparations
DE3264782D1 (en) Medicinal formulation
HK53188A (en) Pharmaceutical formulations
ZA81136B (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
GB2074028B (en) Pharmaceutical formulations
MTP884B (en) Pharmaceutical preparationes
PH17121A (en) Pharmaceutical preparations
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
SG62587G (en) Pharmaceutical formulation
ZA817684B (en) Pharmaceutical compositions
ZA815175B (en) Pharmaceutical composition
AU543418B2 (en) Pharmaceutical formulation
KE3581A (en) Pharmaceutical formulation
IE822854L (en) Pharmaceutical formulation
DK173981A (en) Antigenic pharmaceutical formulation
ZM8681A1 (en) Pharmaceutical compositions
ZA812902B (en) Pharmaceutical compositions
PT73810B (en) Pharmaceutical compositions